A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma
Clinical trial NCT05419388 · COMPLETED
Trial details
- NCT number
- NCT05419388
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2024-05-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.